MAPK11 and cancer: To determine the role of p38 MAPK signalling in the survival of cancer cells exposed to chemotherapeutic agents, we treated human breast and colon cancer cell lines with cisplatin together with SB203580, a chemical inhibitor of p38α and the related family member p38β.